Odyssey Health, Inc. Secures Exclusive Global Distribution Rights for BreastCheck™ to Drive Recurring Revenue Growth
Odyssey Health secured exclusive global marketing and distribution rights for BreastCheck™, a non-invasive at-home screening device for breast abnormalities. The device is registered with the FDA and authorities in the EU and UK, targeting a global market estimated at approximately $26 billion with results available in roughly 15 minutes.
Key figures
- Market size usd
- $26 billion
- Time to result minutes
- 15
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.